RMD SEC filings (2026)
CIK 943819 · Surgical & Medical Instruments & Apparatus (SIC 3841) · incorporated in DE · fiscal year ends in June
2,550 filings on EDGAR since 1996 · 35 annual, 92 quarterly, 205 current · financial statements · earnings
What happened, last 12 months#
Every earnings release with its print, every report with its quarter, the other 8-Ks by the headline of the press release they furnish or by their items, the proxy statements, and each day an insider bought or sold — newest first, each line opening the filing on EDGAR. The index by form and year follows.
October 2026
- Oct 7Insider saleFarrell Michael J. (Chairman and CEO · Director) sold 4,991 shares for $1.1M at $226.33 under a 10b5-1 plan
- Oct 1ProxyProxy · Annual report to shareholders
- Oct 1ProxyProxy · Additional proxy materials
- Oct 1ProxyProxy · Proxy statement
September 2026
August 2026
- Aug 178-K8-K · Resmed Announces Appointment of Carol Burt as Lead Director and Planned Retirement of Director Ron TaylorChange of auditor; Directors or officers; compensation; Regulation FD disclosure
- Aug 13ReportAnnual report, FY2026 — revenue $5.65B (+10% y/y), net income $1.52B, EPS $10.43
- Aug 7Insider saleFarrell Michael J. (Chairman and CEO · Director) sold 4,991 shares for $1.0M at $205.69 under a 10b5-1 plan
- Aug 6EarningsEarnings release — EPS $2.95 vs $2.90 est. (+1.7%); revenue $1.46B (+9% y/y) 5.1%
- Aug 5Insider saleFARRELL PETER C (Director) sold 8,000 shares for $1.8M at $225.00 under a 10b5-1 plan
July 2026
- Jul 7Insider saleFarrell Michael J. (Chairman and CEO · Director) sold 4,991 shares for $1.1M at $218.55 under a 10b5-1 plan
- Jul 78-K8-K · Resmed Announces Agreement to Sell MatrixCare BusinessResults of operations; Regulation FD disclosure
June 2026
May 2026
April 2026
- Apr 30EarningsEarnings release — EPS $2.86 vs $2.79 est. (+2.5%); revenue $1.43B (+11% y/y) 4.1%
- Apr 308-K8-K · Directors or officers; compensation
- Apr 7Insider saleFarrell Michael J. (Chairman and CEO · Director) sold 4,991 shares for $1.1M at $225.50 under a 10b5-1 plan
- Apr 1Insider saleFARRELL PETER C (Director) sold 2,000 shares for $450K at $225.00 under a 10b5-1 plan
- Apr 1Insider saleSandercock Brett (Chief Financial Officer) sold 1,000 shares for $224K at $224.31 under a 10b5-1 plan
March 2026
- Mar 9Insider saleFarrell Michael J. (Chairman and CEO · Director) sold 4,991 shares for $1.3M at $251.03 under a 10b5-1 plan
- Mar 4Insider saleFARRELL PETER C (Director) sold 2,000 shares for $520K at $260.22 under a 10b5-1 plan
- Mar 2Insider saleSandercock Brett (Chief Financial Officer) sold 1,000 shares for $254K at $254.30 under a 10b5-1 plan
February 2026
- Feb 9Insider saleFarrell Michael J. (Chairman and CEO · Director) sold 4,991 shares for $1.4M at $273.78 under a 10b5-1 plan
- Feb 4Insider saleFARRELL PETER C (Director) sold 2,000 shares for $503K at $251.31 under a 10b5-1 plan
- Feb 4Insider saleRider Michael J (Global General Counsel) sold 50 shares for $13K at $260.00 under a 10b5-1 plan
- Feb 2Insider saleSandercock Brett (Chief Financial Officer) sold 1,000 shares for $257K at $257.03 under a 10b5-1 plan
January 2026
- Jan 30ReportQuarterly report, Q2 FY2026 — revenue $1.42B (+11% y/y), net income $392.6M, EPS $2.68
- Jan 29EarningsEarnings release — EPS $2.81 vs $2.69 est. (+4.5%); revenue $1.42B (+11% y/y) 0.3%
- Jan 7Insider saleFarrell Michael J. (Chairman and CEO · Director) sold 4,991 shares for $1.2M at $248.46 under a 10b5-1 plan
- Jan 7Insider saleFARRELL PETER C (Director) sold 2,000 shares for $498K at $248.83 under a 10b5-1 plan
- Jan 2Insider saleSandercock Brett (Chief Financial Officer) sold 1,000 shares for $242K at $241.75 under a 10b5-1 plan
- Jan 2Insider saleRider Michael J (Global General Counsel) sold 50 shares for $12K at $241.75 under a 10b5-1 plan
November 2025
October 2025
Insider transactions#
What officers, directors and 10% holders reported on Forms 4 and 5 over the last 13 months, from the documents themselves: one insider’s trades of one kind on one day are one row, with the shares, the price range and the total as filed. Open-market buys and sells first; awards, exercises, tax withholding, gifts and employee-plan purchases are grouped below them.
Over the last 13 months insiders sold $16.3M in 22 sales and bought nothing on the open market; 25 other transactions (awards, exercises, tax withholding, gifts and plan purchases).
| Date | Insider |
|---|---|
| Oct 7, 2026Form 4 | Farrell Michael J.Chairman and CEO · DirectorSold · $1.1M · 4,991 sh · 10b5-1 |
| Sep 8, 2026Form 4 | Farrell Michael J.Chairman and CEO · DirectorSold · $1.1M · 4,991 sh · 10b5-1 |
| Sep 2, 2026Form 4 | FARRELL PETER CDirectorSold · $228K · 970 sh · 10b5-1 |
| Aug 7, 2026Form 4 | Farrell Michael J.Chairman and CEO · DirectorSold · $1.0M · 4,991 sh · 10b5-1 |
| Aug 5, 2026Form 4 | FARRELL PETER CDirectorSold · $1.8M · 8,000 sh · 10b5-1 |
| Jul 7, 2026Form 4 | Farrell Michael J.Chairman and CEO · DirectorSold · $1.1M · 4,991 sh · 10b5-1 |
| Jun 8, 2026Form 4 | Farrell Michael J.Chairman and CEO · DirectorSold · $968K · 4,991 sh · 10b5-1 |
| May 7, 2026Form 4 | Farrell Michael J.Chairman and CEO · DirectorSold · $1.0M · 4,991 sh · 10b5-1 |
| Apr 7, 2026Form 4 | Farrell Michael J.Chairman and CEO · DirectorSold · $1.1M · 4,991 sh · 10b5-1 |
| Apr 1, 2026Form 4 | FARRELL PETER CDirectorSold · $450K · 2,000 sh · 10b5-1 |
| Apr 1, 2026Form 4 | Sandercock BrettChief Financial OfficerSold · $224K · 1,000 sh · 10b5-1 |
| Mar 9, 2026Form 4 | Farrell Michael J.Chairman and CEO · DirectorSold · $1.3M · 4,991 sh · 10b5-1 |
| Mar 4, 2026Form 4 | FARRELL PETER CDirectorSold · $520K · 2,000 sh · 10b5-1 |
| Mar 2, 2026Form 4 | Sandercock BrettChief Financial OfficerSold · $254K · 1,000 sh · 10b5-1 |
| Feb 9, 2026Form 4 | Farrell Michael J.Chairman and CEO · DirectorSold · $1.4M · 4,991 sh · 10b5-1 |
| Feb 4, 2026Form 4 | FARRELL PETER CDirectorSold · $503K · 2,000 sh · 10b5-1 |
| Feb 4, 2026Form 4 | Rider Michael JGlobal General CounselSold · $13K · 50 sh · 10b5-1 |
| Feb 2, 2026Form 4 | Sandercock BrettChief Financial OfficerSold · $257K · 1,000 sh · 10b5-1 |
| Jan 7, 2026Form 4 | Farrell Michael J.Chairman and CEO · DirectorSold · $1.2M · 4,991 sh · 10b5-1 |
| Jan 7, 2026Form 4 | FARRELL PETER CDirectorSold · $498K · 2,000 sh · 10b5-1 |
| Jan 2, 2026Form 4 | Sandercock BrettChief Financial OfficerSold · $242K · 1,000 sh · 10b5-1 |
| Jan 2, 2026Form 4 | Rider Michael JGlobal General CounselSold · $12K · 50 sh · 10b5-1 |
Awards, exercises, withholding and plan purchases · 25 transactions
| Date | Insider |
|---|---|
| Oct 7, 2026Form 4 | Farrell Michael J.Chairman and CEO · DirectorExercise or conversion · $730K · 4,991 sh · 10b5-1 |
| Oct 7, 2026Form 4 | Farrell Michael J.Chairman and CEO · DirectorExercise or conversion · ResMed Common Stock Options · $0 · 4,991 sh · 10b5-1 |
| Sep 8, 2026Form 4 | Farrell Michael J.Chairman and CEO · DirectorExercise or conversion · $730K · 4,991 sh · 10b5-1 |
| Sep 8, 2026Form 4 | Farrell Michael J.Chairman and CEO · DirectorExercise or conversion · ResMed Common Stock Options · $0 · 4,991 sh · 10b5-1 |
| Aug 14, 2026Form 4 | Farrell Michael J.Chairman and CEO · DirectorAward · $0 · 13,547 sh |
| Aug 14, 2026Form 4 | Bloomer AaronChief Financial OfficerAward · $0 · 9,072 sh |
| Aug 14, 2026Form 4 | Leong JustinChief Product OfficerAward · $0 · 6,461 sh |
| Aug 14, 2026Form 4 | Rider Michael JGlobal General CounselAward · $0 · 3,230 sh |
| Aug 7, 2026Form 4 | Farrell Michael J.Chairman and CEO · DirectorExercise or conversion · $730K · 4,991 sh · 10b5-1 |
| Aug 7, 2026Form 4 | Farrell Michael J.Chairman and CEO · DirectorExercise or conversion · ResMed Common Stock Options · $0 · 4,991 sh · 10b5-1 |
| Jul 7, 2026Form 4 | Farrell Michael J.Chairman and CEO · DirectorExercise or conversion · $730K · 4,991 sh · 10b5-1 |
| Jul 7, 2026Form 4 | Farrell Michael J.Chairman and CEO · DirectorExercise or conversion · ResMed Common Stock Options · $0 · 4,991 sh · 10b5-1 |
| Jun 8, 2026Form 4 | Farrell Michael J.Chairman and CEO · DirectorExercise or conversion · $730K · 4,991 sh · 10b5-1 |
| Jun 8, 2026Form 4 | Farrell Michael J.Chairman and CEO · DirectorExercise or conversion · ResMed Common Stock Options · $0 · 4,991 sh · 10b5-1 |
| Jun 1, 2026Form 4 | Rider Michael JGlobal General CounselTax withholding · $51K · 268.742 sh |
| May 7, 2026Form 4 | Farrell Michael J.Chairman and CEO · DirectorExercise or conversion · $730K · 4,991 sh · 10b5-1 |
| May 7, 2026Form 4 | Farrell Michael J.Chairman and CEO · DirectorExercise or conversion · ResMed Common Stock Options · $0 · 4,991 sh · 10b5-1 |
| Apr 7, 2026Form 4 | Farrell Michael J.Chairman and CEO · DirectorExercise or conversion · $730K · 4,991 sh · 10b5-1 |
| Apr 7, 2026Form 4 | Farrell Michael J.Chairman and CEO · DirectorExercise or conversion · ResMed Common Stock Options · $0 · 4,991 sh · 10b5-1 |
| Mar 9, 2026Form 4 | Farrell Michael J.Chairman and CEO · DirectorExercise or conversion · $730K · 4,991 sh · 10b5-1 |
| Mar 9, 2026Form 4 | Farrell Michael J.Chairman and CEO · DirectorExercise or conversion · ResMed Common Stock Options · $0 · 4,991 sh · 10b5-1 |
| Feb 9, 2026Form 4 | Farrell Michael J.Chairman and CEO · DirectorExercise or conversion · $730K · 4,991 sh · 10b5-1 |
| Feb 9, 2026Form 4 | Farrell Michael J.Chairman and CEO · DirectorExercise or conversion · ResMed Common Stock Options · $0 · 4,991 sh · 10b5-1 |
| Jan 7, 2026Form 4 | Farrell Michael J.Chairman and CEO · DirectorExercise or conversion · $730K · 4,991 sh · 10b5-1 |
| Jan 7, 2026Form 4 | Farrell Michael J.Chairman and CEO · DirectorExercise or conversion · ResMed Common Stock Options · $0 · 4,991 sh · 10b5-1 |
Reports and proxy statements#
Annual reports (10-K, 20-F, 40-F), quarterly reports (10-Q), current reports (8-K, 6-K) and proxy statements, newest first. An 8-K that furnishes a press release is headed by the release’s headline, its items beneath; any other 8-K is described by its items. A form opens the press release where there is one, else the document on EDGAR, or the filing’s index where it furnishes other exhibits.
2026 · 13 filings
| Filed | What it is |
|---|---|
| Oct 1, 2026ARS | Annual report to shareholders |
| Oct 1, 2026DEFA14A | Additional proxy materials |
| Oct 1, 2026DEF 14A | Proxy statement |
| Sep 1, 20268-K | Other events |
| Aug 17, 20268-K | Resmed Announces Appointment of Carol Burt as Lead Director and Planned Retirement of Director Ron TaylorChange of auditor; Directors or officers; compensation; Regulation FD disclosure |
| Aug 13, 202610-K | Annual report, FY2026 — revenue $5.65B (+10% y/y), net income $1.52B, EPS $10.43 |
| Aug 6, 20268-K | Earnings release — EPS $2.95 vs $2.90 est. (+1.7%); revenue $1.46B (+9% y/y) 5.1% |
| Jul 7, 20268-K | Resmed Announces Agreement to Sell MatrixCare BusinessResults of operations; Regulation FD disclosure |
| May 1, 202610-Q | Quarterly report, Q3 2026 — revenue $1.43B (+11% y/y), net income $398.7M, EPS $2.74 |
| Apr 30, 20268-K | Directors or officers; compensation |
| Apr 30, 20268-K | Earnings release — EPS $2.86 vs $2.79 est. (+2.5%); revenue $1.43B (+11% y/y) 4.1% |
| Jan 30, 202610-Q | Quarterly report, Q2 FY2026 — revenue $1.42B (+11% y/y), net income $392.6M, EPS $2.68 |
| Jan 29, 20268-K | Earnings release — EPS $2.81 vs $2.69 est. (+4.5%); revenue $1.42B (+11% y/y) 0.3% |
2025 · 14 filings
| Filed | What it is |
|---|---|
| Nov 20, 20258-K | Directors or officers; compensation; Shareholder vote results |
| Oct 31, 202510-Q | Quarterly report, Q1 FY2026 — revenue $1.34B (+9% y/y), net income $348.5M, EPS $2.37 |
| Oct 30, 20258-K | Earnings release — EPS $2.55 vs $2.49 est. (+2.4%); revenue $1.34B (+9% y/y) 2.1% |
| Oct 2, 2025ARS | Annual report to shareholders |
| Oct 2, 2025DEFA14A | Additional proxy materials |
| Oct 2, 2025DEF 14A | Proxy statement |
| Aug 18, 20258-K | Directors or officers; compensation |
| Aug 8, 202510-K | Annual report, FY2025 — revenue $5.15B (+10% y/y), net income $1.40B, EPS $9.51 |
| Aug 1, 20258-K | Directors or officers; compensation |
| Jul 31, 20258-K | Earnings release — EPS $2.55 vs $2.46 est. (+3.7%); revenue $1.35B (+10% y/y) 2.7% |
| Apr 24, 202510-Q | Quarterly report, Q3 2025 — revenue $1.29B (+8% y/y), net income $365.0M, EPS $2.48 |
| Apr 23, 20258-K | Earnings release — EPS $2.37 vs $2.36 est. (+0.4%); revenue $1.29B (+8% y/y) 10.1% |
| Jan 31, 202510-Q | Quarterly report, Q2 FY2025 — revenue $1.28B (+10% y/y), net income $344.6M, EPS $2.34 |
| Jan 30, 20258-K | Earnings release — EPS $2.43 vs $2.30 est. (+5.7%); revenue $1.28B (+10% y/y) 8.3% |
2024 · 14 filings
| Filed | What it is |
|---|---|
| Nov 21, 20248-K | Shareholder vote results |
| Oct 25, 2024DEFA14A | Additional proxy materials |
| Oct 25, 202410-Q | Quarterly report, Q1 FY2025 — revenue $1.22B (+11% y/y), net income $311.4M, EPS $2.11 |
| Oct 24, 20248-K | Earnings release — EPS $2.20 vs $2.03 est. (+8.4%); revenue $1.22B (+11% y/y) 7.1% |
| Oct 3, 2024ARS | Annual report to shareholders |
| Oct 3, 2024DEFA14A | Additional proxy materials |
| Oct 3, 2024DEF 14A | Proxy statement |
| Aug 16, 20248-K | Directors or officers; compensation |
| Aug 9, 202410-K | Annual report, FY2024 — revenue $4.69B (+11% y/y), net income $1.02B, EPS $6.92 |
| Aug 1, 20248-K | Earnings release — EPS $2.08 vs $2.03 est. (+2.5%); revenue $1.22B (+9% y/y) 4.2% |
| Apr 26, 202410-Q | Quarterly report, Q3 2024 — revenue $1.20B (+7% y/y), net income $300.5M, EPS $2.04 |
| Apr 25, 20248-K | Earnings release — EPS $2.13 vs $1.92 est. (+10.9%); revenue $1.20B (+7% y/y) 18.9% |
| Jan 25, 202410-Q | Quarterly report, Q2 FY2024 — revenue $1.16B (+12% y/y), net income $208.8M, EPS $1.42 |
| Jan 24, 20248-K | Earnings release — EPS $1.88 vs $1.81 est. (+3.9%); revenue $1.16B (+12% y/y) 8.5% |
2023 · 15 filings — 7 × 8-K, 3 × 10-Q, 1 × 10-K and 4 other forms
| Filed | What it is |
|---|---|
| Oct 27, 202310-Q | Quarterly report, Q1 FY2024 — revenue $1.10B (+16% y/y), net income $219.4M, EPS $1.49 |
| Oct 13, 2023DEFR14A | Proxy statements |
| Oct 5, 2023ARS | Annual report to shareholders |
| Oct 5, 2023DEFA14A | Additional proxy materials |
| Oct 5, 2023DEF 14A | Proxy statement |
| Aug 11, 202310-K | Annual report, FY2023 — revenue $4.22B (+18% y/y), net income $897.6M, EPS $6.09 |
| Apr 28, 202310-Q | Quarterly report, Q3 2023 — revenue $1.12B (+29% y/y), net income $232.5M, EPS $1.58 |
| Jan 27, 202310-Q | Quarterly report, Q2 FY2023 — revenue $1.03B (+16% y/y), net income $224.9M, EPS $1.53 |
7 current reports (8-K) not listed; the year is on EDGAR.
2022 · 16 filings — 9 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
| Filed | What it is |
|---|---|
| Oct 28, 202210-Q | Quarterly report, Q1 FY2023 — revenue $950.3M (+5% y/y), net income $210.5M, EPS $1.43 |
| Oct 5, 2022DEFA14A | Additional proxy materials |
| Oct 5, 2022DEF 14A | Proxy statement |
| Aug 12, 202210-K | Annual report, FY2022 — revenue $3.58B (+12% y/y), net income $779.4M, EPS $5.30 |
| Apr 29, 202210-Q | Quarterly report, Q3 2022 — revenue $864.5M (+12% y/y), net income $179.0M, EPS $1.22 |
| Jan 28, 202210-Q | Quarterly report, Q2 FY2022 — revenue $894.9M (+12% y/y), net income $201.8M, EPS $1.37 |
10 current reports (8-K) not listed; the year is on EDGAR.
2021 · 16 filings — 7 × 8-K, 3 × 10-Q, 2 × 10-K/A and 4 other forms
| Filed | What it is |
|---|---|
| Oct 29, 202110-Q | Quarterly report, Q1 FY2022 — revenue $904.0M (+20% y/y), net income $203.6M, EPS $1.39 |
| Oct 6, 2021DEFA14A | Additional proxy materials |
| Oct 6, 2021DEF 14A | Proxy statement |
| Aug 19, 202110-K/A | Annual report, amended |
| Aug 17, 202110-K | Annual report, FY2021 — revenue $3.20B (+8% y/y), net income $474.5M, EPS $3.24 |
| Apr 30, 202110-Q | Quarterly report, Q3 2021 — revenue $768.8M (−0% y/y), net income −$78.5M, EPS −$0.54 |
| Mar 30, 202110-K/A | Annual report, amended |
| Jan 29, 202110-Q | Quarterly report, Q2 FY2021 — revenue $800.0M (+9% y/y), net income $179.5M, EPS $1.23 |
8 current reports (8-K) not listed; the year is on EDGAR.
2020 · 13 filings — 6 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
| Filed | What it is |
|---|---|
| Oct 30, 202010-Q | Quarterly report, Q1 FY2021 — revenue $751.9M (+10% y/y), net income $178.4M, EPS $1.22 |
| Oct 6, 2020DEFA14A | Additional proxy materials |
| Oct 6, 2020DEF 14A | Proxy statement |
| Aug 13, 202010-K | Annual report, FY2020 — revenue $2.96B (+13% y/y), net income $621.7M, EPS $4.27 |
| May 1, 202010-Q | Quarterly report, Q3 2020 — revenue $769.5M (+16% y/y), net income $163.1M, EPS $1.12 |
| Jan 31, 202010-Q | Quarterly report, Q2 FY2020 — revenue $736.2M (+13% y/y), net income $160.6M, EPS $1.10 |
7 current reports (8-K) not listed; the year is on EDGAR.
2019 · 15 filings — 7 × 8-K, 3 × 10-Q, 2 × 8-K/A and 3 other forms
| Filed | What it is |
|---|---|
| Oct 25, 201910-Q | Quarterly report, Q1 FY2020 — revenue $681.1M (+16% y/y), net income $120.1M, EPS $0.83 |
| Oct 8, 2019DEFA14A | Additional proxy materials |
| Oct 8, 2019DEF 14A | Proxy statement |
| Aug 8, 201910-K | Annual report, FY2019 — revenue $2.61B (+11% y/y), net income $404.6M, EPS $2.80 |
| May 3, 201910-Q | Quarterly report, Q3 2019 — revenue $662.2M (+12% y/y), net income $105.4M, EPS $0.73 |
| Feb 1, 201910-Q | Quarterly report, Q2 FY2019 — revenue $651.1M (+8% y/y), net income $124.6M, EPS $0.86 |
9 current reports (8-K) not listed; the year is on EDGAR.
2018 · 16 filings — 9 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
| Filed | What it is |
|---|---|
| Oct 31, 2018DEFR14A | Proxy statements |
| Oct 26, 201810-Q | Quarterly report, Q1 FY2019 — revenue $588.3M (+12% y/y), net income $105.7M, EPS $0.73 |
| Oct 3, 2018DEFA14A | Additional proxy materials |
| Oct 3, 2018DEF 14A | Proxy statement |
| Aug 17, 201810-K | Annual report, FY2018 — revenue $2.34B (+13% y/y), net income $315.6M, EPS $2.19 |
| Apr 27, 201810-Q | Quarterly report, Q3 2018 — revenue $591.6M, net income $110.1M, EPS $0.76 |
| Jan 24, 201810-Q | Quarterly report, Q2 FY2018 — revenue $601.3M, net income $9.5M, EPS $0.07 |
9 current reports (8-K) not listed; the year is on EDGAR.
2017 · 13 filings — 6 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
| Filed | What it is |
|---|---|
| Oct 27, 201710-Q | Quarterly report, Q1 FY2018 — revenue $523.7M, net income $86.1M, EPS $0.60 |
| Sep 26, 2017DEFA14A | Additional proxy materials |
| Sep 25, 2017DEF 14A | Proxy statement |
| Aug 4, 201710-K | Annual report, FY2017 — revenue $2.07B (+12% y/y), net income $342.3M, EPS $2.40 |
| Apr 28, 201710-Q | Quarterly report, Q3 2017 — net income $87.8M, EPS $0.62 |
| Jan 25, 201710-Q | Quarterly report, Q2 FY2017 — net income $76.7M, EPS $0.54 |
| Jan 13, 201710-K/A | Annual report, amended |
6 current reports (8-K) not listed; the year is on EDGAR.
2016 · 13 filings — 7 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2015 · 12 filings — 6 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2014 · 14 filings — 8 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2013 · 14 filings — 7 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
Counted, not listed; the year is on EDGAR.
2012 · 16 filings — 9 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
Counted, not listed; the year is on EDGAR.
2011 · 17 filings — 10 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
Counted, not listed; the year is on EDGAR.
2010 · 15 filings — 7 × 8-K, 3 × 10-Q, 1 × 10-K and 4 other forms
Counted, not listed; the year is on EDGAR.
2009 · 16 filings — 10 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2008 · 16 filings — 11 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form
Counted, not listed; the year is on EDGAR.
2007 · 16 filings — 10 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2006 · 15 filings — 9 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2005 · 17 filings — 10 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
Counted, not listed; the year is on EDGAR.
2004 · 11 filings — 6 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form
Counted, not listed; the year is on EDGAR.
2003 · 9 filings — 4 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form
Counted, not listed; the year is on EDGAR.
2002 · 7 filings — 3 × 10-Q, 2 × 8-K, 1 × 10-K and 1 other form
Counted, not listed; the year is on EDGAR.
2001 · 10 filings — 4 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2000 · 6 filings — 3 × 10-Q, 1 × 10-K, 1 × DEF 14A and 1 other form
Counted, not listed; the year is on EDGAR.
1999 · 6 filings — 3 × 10-Q, 1 × 10-K, 1 × 8-K and 1 other form
Counted, not listed; the year is on EDGAR.
1998 · 6 filings — 3 × 10-Q, 1 × 10-K, 1 × DEF 14A and 1 other form
Counted, not listed; the year is on EDGAR.
1997 · 7 filings — 3 × 10-Q, 2 × DEF 14A, 1 × 10-K and 1 other form
Counted, not listed; the year is on EDGAR.
1996 · 5 filings — 2 × 10-Q, 1 × 10-K, 1 × 10-K/A and 1 other form
Counted, not listed; the year is on EDGAR.
Insider, ownership and other filings#
Insider ownership (Forms 3, 4, 5 and 144), beneficial ownership (Schedules 13D and 13G), registration and prospectus (S-1, S-3, S-8, 424B and related) and the rest, counted by year, with the newest 25 of each of the latest 3 years shown. A Form 4 is one insider’s transaction report; a 13G is a passive holder above five percent.
2026 · 59 filings — 28 × 4, 23 × 144, 3 × SCHEDULE 13G and 4 other forms
| Filed | What it is |
|---|---|
| Oct 8, 20264 | Insider transaction (Form 4) |
| Oct 7, 2026144 | Notice of proposed sale (Form 144) |
| Oct 1, 20264/A | Insider transaction (Form 4), amended |
| Oct 1, 20264 | Insider transaction (Form 4) |
| Oct 1, 20264 | Insider transaction (Form 4) |
| Oct 1, 20264 | Insider transaction (Form 4) |
| Oct 1, 20264 | Insider transaction (Form 4) |
| Sep 10, 20264 | Insider transaction (Form 4) |
| Sep 8, 2026144 | Notice of proposed sale (Form 144) |
| Sep 4, 20264 | Insider transaction (Form 4) |
| Sep 2, 2026144 | Notice of proposed sale (Form 144) |
| Aug 11, 20264 | Insider transaction (Form 4) |
| Aug 7, 2026SCHEDULE 13G | Other filings |
| Aug 7, 2026144 | Notice of proposed sale (Form 144) |
| Aug 6, 20264 | Insider transaction (Form 4) |
| Aug 5, 2026144 | Notice of proposed sale (Form 144) |
| Jul 9, 20264 | Insider transaction (Form 4) |
| Jul 7, 2026144 | Notice of proposed sale (Form 144) |
| Jul 1, 2026SCHEDULE 13G/A | Other filings |
| Jun 9, 20264 | Insider transaction (Form 4) |
| Jun 8, 2026144 | Notice of proposed sale (Form 144) |
| Jun 3, 20264 | Insider transaction (Form 4) |
| May 27, 2026144 | Notice of proposed sale (Form 144) |
| May 26, 2026SD | Specialized disclosure (conflict minerals) |
| May 11, 20264 | Insider transaction (Form 4) |
The newest 25 of 59 shown; the full year is on EDGAR.
2025 · 127 filings — 74 × 4, 48 × 144, 2 × S-8 and 3 other forms
| Filed | What it is |
|---|---|
| Dec 9, 20254 | Insider transaction (Form 4) |
| Dec 8, 2025144 | Notice of proposed sale (Form 144) |
| Dec 4, 20254 | Insider transaction (Form 4) |
| Dec 3, 2025144 | Notice of proposed sale (Form 144) |
| Dec 2, 20254 | Insider transaction (Form 4) |
| Dec 2, 20254 | Insider transaction (Form 4) |
| Dec 1, 2025144 | Notice of proposed sale (Form 144) |
| Dec 1, 2025144 | Notice of proposed sale (Form 144) |
| Nov 26, 20254 | Insider transaction (Form 4) |
| Nov 26, 20254 | Insider transaction (Form 4) |
| Nov 26, 20254 | Insider transaction (Form 4) |
| Nov 26, 20254 | Insider transaction (Form 4) |
| Nov 25, 2025144 | Notice of proposed sale (Form 144) |
| Nov 24, 20254 | Insider transaction (Form 4) |
| Nov 24, 20254 | Insider transaction (Form 4) |
| Nov 24, 20254 | Insider transaction (Form 4) |
| Nov 24, 20254 | Insider transaction (Form 4) |
| Nov 24, 20254 | Insider transaction (Form 4) |
| Nov 24, 20254 | Insider transaction (Form 4) |
| Nov 24, 20254 | Insider transaction (Form 4) |
| Nov 24, 20254 | Insider transaction (Form 4) |
| Nov 24, 20254 | Insider transaction (Form 4) |
| Nov 24, 20254 | Insider transaction (Form 4) |
| Nov 24, 20254 | Insider transaction (Form 4) |
| Nov 24, 20254 | Insider transaction (Form 4) |
The newest 25 of 127 shown; the full year is on EDGAR.
2024 · 102 filings — 61 × 4, 35 × 144, 2 × SC 13G/A and 4 other forms
| Filed | What it is |
|---|---|
| Dec 11, 20244 | Insider transaction (Form 4) |
| Dec 9, 2024144 | Notice of proposed sale (Form 144) |
| Dec 5, 20244 | Insider transaction (Form 4) |
| Dec 4, 2024144 | Notice of proposed sale (Form 144) |
| Dec 2, 20244 | Insider transaction (Form 4) |
| Dec 2, 2024144 | Notice of proposed sale (Form 144) |
| Nov 27, 2024144 | Notice of proposed sale (Form 144) |
| Nov 27, 20244 | Insider transaction (Form 4) |
| Nov 26, 20244 | Insider transaction (Form 4) |
| Nov 25, 20244 | Insider transaction (Form 4) |
| Nov 22, 2024144 | Notice of proposed sale (Form 144) |
| Nov 22, 20244 | Insider transaction (Form 4) |
| Nov 22, 20244 | Insider transaction (Form 4) |
| Nov 22, 20244 | Insider transaction (Form 4) |
| Nov 22, 20244 | Insider transaction (Form 4) |
| Nov 22, 20244 | Insider transaction (Form 4) |
| Nov 22, 20244 | Insider transaction (Form 4) |
| Nov 22, 20244 | Insider transaction (Form 4) |
| Nov 22, 20244 | Insider transaction (Form 4) |
| Nov 22, 20244 | Insider transaction (Form 4) |
| Nov 22, 20244 | Insider transaction (Form 4) |
| Nov 14, 20244 | Insider transaction (Form 4) |
| Nov 12, 20244 | Insider transaction (Form 4) |
| Nov 12, 20244 | Insider transaction (Form 4) |
| Nov 12, 20244 | Insider transaction (Form 4) |
The newest 25 of 102 shown; the full year is on EDGAR.
2023 · 114 filings — 70 × 4, 35 × 144, 4 × SC 13G/A and 4 other forms
Counted, not listed; the year is on EDGAR.
2022 · 82 filings — 73 × 4, 3 × SC 13G/A, 2 × 4/A and 3 other forms
Counted, not listed; the year is on EDGAR.
2021 · 120 filings — 105 × 4, 3 × 3, 3 × 4/A and 6 other forms
Counted, not listed; the year is on EDGAR.
2020 · 111 filings — 100 × 4, 4 × 4/A, 3 × SC 13G/A and 4 other forms
Counted, not listed; the year is on EDGAR.
2019 · 119 filings — 112 × 4, 4 × SC 13G/A, 1 × 3 and 2 other forms
Counted, not listed; the year is on EDGAR.
2018 · 96 filings — 89 × 4, 3 × SC 13G/A, 1 × 3 and 3 other forms
Counted, not listed; the year is on EDGAR.
2017 · 105 filings — 89 × 4, 5 × SC 13G/A, 4 × 4/A and 4 other forms
Counted, not listed; the year is on EDGAR.
2016 · 84 filings — 76 × 4, 3 × SC 13G/A, 2 × 4/A and 3 other forms
Counted, not listed; the year is on EDGAR.
2015 · 109 filings — 98 × 4, 3 × SC 13G/A, 2 × 4/A and 4 other forms
Counted, not listed; the year is on EDGAR.
2014 · 90 filings — 84 × 4, 2 × SC 13G, 2 × SC 13G/A and 2 other forms
Counted, not listed; the year is on EDGAR.
2013 · 78 filings — 70 × 4, 3 × SC 13G, 2 × 4/A and 3 other forms
Counted, not listed; the year is on EDGAR.
2012 · 61 filings — 55 × 4, 2 × 4/A, 2 × SC 13G/A and 2 other forms
Counted, not listed; the year is on EDGAR.
2011 · 52 filings — 48 × 4, 2 × 4/A, 2 × SC 13G/A
Counted, not listed; the year is on EDGAR.
2010 · 79 filings — 69 × 4, 3 × 4/A, 2 × 3 and 4 other forms
Counted, not listed; the year is on EDGAR.
2009 · 62 filings — 55 × 4, 4 × 4/A, 2 × SC 13G/A and 1 other form
Counted, not listed; the year is on EDGAR.
2008 · 44 filings — 37 × 4, 2 × SC 13G/A, 2 × UPLOAD and 3 other forms
Counted, not listed; the year is on EDGAR.
2007 · 58 filings — 50 × 4, 4 × SC 13G/A, 2 × S-8 and 2 other forms
Counted, not listed; the year is on EDGAR.
2006 · 71 filings — 54 × 4, 8 × 4/A, 3 × CORRESP and 3 other forms
Counted, not listed; the year is on EDGAR.
2005 · 92 filings — 80 × 4, 5 × 3, 3 × 4/A and 3 other forms
Counted, not listed; the year is on EDGAR.
2004 · 82 filings — 74 × 4, 3 × 4/A, 2 × SC 13G and 3 other forms
Counted, not listed; the year is on EDGAR.
2003 · 99 filings — 75 × 4, 15 × 4/A, 5 × SC 13G/A and 3 other forms
Counted, not listed; the year is on EDGAR.
2002 · 16 filings — 5 × 424B3, 4 × SC 13G/A, 3 × 4 and 4 other forms
Counted, not listed; the year is on EDGAR.
2001 · 14 filings — 7 × 424B3, 5 × SC 13G/A, 1 × S-3 and 1 other form
Counted, not listed; the year is on EDGAR.
2000 · 7 filings — 4 × SC 13G/A, 3 × SC 13G
Counted, not listed; the year is on EDGAR.
1999 · 7 filings — 5 × SC 13G/A, 1 × 8-A12B, 1 × S-8
Counted, not listed; the year is on EDGAR.
1998 · 7 filings — 5 × SC 13G/A, 2 × SC 13G
Counted, not listed; the year is on EDGAR.
1997 · 5 filings — 2 × SC 13G, 2 × SC 13G/A, 1 × 8-A12G
Counted, not listed; the year is on EDGAR.
1996 · 5 filings — 3 × SC 13G, 1 × POS AM, 1 × S-8
Counted, not listed; the year is on EDGAR.
About this data#
ResMed Inc. (RMD) has 2,550 filings on EDGAR going back to 1996: 35 annual reports, 92 quarterly reports and 205 current reports, plus proxy statements, insider forms and ownership schedules. Its latest annual report, a 10-K, was filed on Aug 13, 2026 for the fiscal year ended Jun 30, 2026. The most recent 8-K, on Sep 1, 2026, covered other events. Over the last 13 months insiders sold $16.3M in 22 sales and bought nothing on the open market; 25 other transactions (awards, exercises, tax withholding, gifts and plan purchases). Not investment advice.
Every row is a filing EDGAR lists for the registrants that have been ResMed Inc., read from the SEC’s submissions index each morning; a filing accepted after that read appears the next day. Where a company changed its filing entity (a holding-company reorganisation, Google into Alphabet) the predecessor’s filings are shown for the years it filed as the company, derived from the filings themselves. Dates are the filing date; the period is the report’s own. The latest 3 years of reports are listed in full, the next years to 10 without their 8-Ks, and older years are counted; the other forms are counted too, with the newest 25 of each of the latest 3 years shown. Insider transactions are the Form 4 and Form 5 documents themselves, filed since January 2026, every number as the insider filed it: a day’s lots are summed, a blank price adds its shares and no dollars, and a purchase through an employee stock plan is a plan purchase, not insider buying. An 8-K’s headline is the first line of the press release it furnishes (Exhibit 99), read from the filing and shown word for word; where two independent readings of the exhibit do not agree, the 8-K is described by its items instead. The documents stay on sec.gov, public domain, and every link opens the SEC’s copy. ChartRow does not summarise or interpret filings.
FAQ#
- Where can I read RMD's latest 10-K?
- RMD's latest annual report, a 10-K, was filed on Aug 13, 2026 for the fiscal year ended Jun 30, 2026. It is linked above and opens on EDGAR, the SEC's own site, where every exhibit is also listed.
- When did RMD last file an 8-K?
- On Sep 1, 2026 it covered other events. An 8-K reports a material event between quarterly reports; the one that furnishes the quarter's results is filed under Item 2.02, last on Aug 6, 2026.
- Are RMD insiders buying or selling?
- Over the last 13 months insiders sold $16.3M in 22 sales and bought nothing on the open market; 25 other transactions (awards, exercises, tax withholding, gifts and plan purchases). The most recent sale: Farrell Michael J. (Chairman and CEO · Director) sold 4,991 shares on Oct 7, 2026 for $1.1M, under a 10b5-1 plan. Every figure is as the insider filed it on Form 4; a sale under a 10b5-1 plan was scheduled in advance.
- How many SEC filings has RMD made?
- 2,550 filings are on EDGAR under the registrant records that have been ResMed Inc., going back to 1996; 1,967 of them are insider ownership forms (Forms 3, 4, 5 and 144).